Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting
Z

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 NAPOLI 3 Trial - NALIRIFOX vs. nab-Paclitaxel + Gemcitabine in Treatment-Naïve Patients With mPDAC"

By Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting FEATURING Zev A. Wainberg
By Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting FEATURING Zev A. Wainberg
184 views
July 17, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Recommended

21:33

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

465 views

·

3 months ago
12:50

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

718 views

·

5 months ago
09:01

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

523 views

·

7 months ago
09:54

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

254 views

·

1 month ago
27:37

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

4.1K views

·

1 year ago
08:34

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Yale Cancer Center

J. Lacy

591 views

·

8 months ago
31:40

Updates in Perioperative Therapy of Pancreatic Cancer

Horizon CME

P. Philip

568 views

·

6 months ago
23:58

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

3.1K views

·

1 year ago
20:07

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

1.6K views

·

1 year ago
07:42

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

W. Burns

254 views

·

7 months ago
04:25

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX v…

ecancer

J. Knox

196 views

·

5 months ago
12:27

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Ad…

2024 ASCO® Annual Meeting Insights Hub

J. Knox

164 views

·

4 months ago
12:08

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Yale Cancer Center

J. Lacy

237 views

·

8 months ago
03:50

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

UCLA Health

Z. Wainberg

286 views

·

8 months ago
07:37

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro i…

2024 ASCO® Annual Meeting Insights Hub

B. Weinberg

195 views

·

5 months ago
21:03

Clinical Takeaways in From Recent Key Trials in Pancreatic Cancer

Hani Babiker

130 views

·

2 months ago
10:53

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Yale Cancer Center

J. Lacy

207 views

·

8 months ago
08:08

Updates in Nonmetastatic Upper-GI Adenocarcinoma

Integrity CE

J. Hernandez

160 views

·

7 months ago
07:53

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Total Health

D. Lin

296 views

·

1 year ago
25:56

Year in Review: Pancreatic Cancers

OncoAlert

M. Lewis

226 views

·

8 months ago
AUTOPLAY